Pharmaceutical product registration Kazakhstan  Imexpharma twitter  eng | қаз | rus
Distribution medicine


An innovative pharmaceutical industry which meets the needs of society

more ...

Tuesday, 05 October 2010

European Medicines Agency and U.S. Food and Drug Administration extend confidentiality arrangements

more ...

Monday, 20 September 2010

New Report shows investment in malaria prevention paying off

more ...

Wednesday, 15 September 2010

Ukraine's antimonopoly committee fines pharma for illegal price hikes

Ukraine's antimonopoly committee (AMKU) has conducted 259 inspections of pharmaceutical manufacturers, wholesalers and retailers and initiated 101 legal investigations of competition law violations by the industry and regional healthcare authorities.

Source: 07.01.2010.

Turkmenistan faces "health crisis" unless TB treatment quickened, MSF warns

Planned programmes to tackle tuberculosis in Turkmenistan may not reach patients until 2013, despite high numbers of cases and growing transmission of multi-drug resistance, Médecins Sans Frontières (MSF) has warned.

Source: 06.01.2010.

Zydus begins H1N1 trials

Zydus Cadila has become the first Indian pharma company to begin multi-centre clinical trials of a H1N1 vaccine after it received approval from the Drug Controller General of India (DCGI).

Source: in-Pharma tehnologist 05.01.2010.

Corrupt Practices Cost Healthcare $23 Billion

Fraud and abuse in healthcare costs individual governments as much as $23 billion a year, according to estimates from the World Health Organization (WHO).


The U.S. Food and Drug Administration (FDA)

The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.

Source: the medical news

The role of pharmacists hasn't received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce treatment costs and improve outcomes.


Uzbekistan is developing international collaborations in order to benefit from more advanced approaches to pharmaceutical production, after it signed agreements with at least two foreign companies in the second half of 2009.